查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1136914

2022-2029 年护理点数据管理系统的全球市场

Global Point Of Care Data Management Systems Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

床旁数据管理系统的市场增长受到数据管理系统技术进步的推动，例如远程监控、床旁数据管理系统的广泛引入、生活方式相关疾病的发病率增加，以及医疗费用的增加。

医疗点数据管理系统对健康记录的需求不断增长，预计将推动市场增长

医疗记录床旁数据管理系统的日益普及预计将在预测期内推动市场增长。根据 2020 年 11 月发表在《实用检验医学》上的一篇文章，认证和监管标准凸显了将 POC 测试结果整合到患者电子病历中的日益增长的需求。这有助于监测和跟踪 POCT 结果的可访问性、能力，防止不必要的重复测试，并提供患者结果的证据。由于 POCT 结果用于临床决策，相关参考区间、测量单位、适用的临界值、测试日期和时间，以及仪器序列号、操作员识别号、试剂批号、质量控制（QC ) ) 记录结果很重要，以便可以追溯到结果。此外，POCT 结果应与其他中心实验室结果明显区分开来，以避免来自不同分析技术的结果混淆或漂移。 POCT 现在已成为所有医院的常规手术，并已成为其他各种医疗环境中患者护理的标准。

此外，主要参与者正在采用市场策略。例如，2020 年 3 月，西门子 Healthmeyers 和 Marienhaus 医院集团建立了为期 10 年的技术合作伙伴关係，并可选择再延长 5 年。 Siemens Healthineas 与 Marienhaus 一起制定了一项数字化战略，将 18 家医院相互连接并简化临床流程。这可能允许更换和管理德国北莱茵州的约 130 台医学成像机器。

缺乏熟练的专业人员阻碍了市场增长

但是，就员工而言，有各种就业形式，例如全职和兼职就业，以及跨多个医院病房和基地的安置。缺乏熟练的专业人员和医护人员来操作数据管理系统正在限制市场的增长。

COVID-19 影响分析

COVID-19 的出现对全球即时数据管理系统市场产生了重大影响。根据 2022 年 5 月发表在《医学实验室观察员》上的一篇文章，在 COVID-19 大流行之前，POC 测试已经经历了强劲的增长和高度的接受。由于大流行，人们更加关注以更实惠的成本改善人们的健康。特别是当快速检测对下游成本和患者结果产生重大影响时，对 POC 检测的需求变得更加强烈。随着疫情的发展，POC检测的价值和快速检测结果的重要性得到了极大的认可，对高可靠性检测方法的需求也随之增加。领先的公司正在提供改进的方法和接口设备来满足这一需求，从而推动广泛采用。由于 POC 测试站点可能广泛分布在整个医疗园区，因此拥有一个强大的 POC 测试管理系统来捕获关键测试信息和管理法规遵从性至关重要。随着对 POC 需求的增加，市场对管理系统的需求也在增加。

全球医疗点数据管理系统市场报告将提供对大约 65 多个市场数据表、65 多个数字和 200 多页（大约）的访问。

内容

第一章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按组件划分的市场细分
  • 按分销形式划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 技术进步
      • 扩大引入电子病历 (EHR)
    • 约束因素
      • 缺乏熟练的专业人员
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 供应链分析
  • 监管分析
  • 定价分析
  • 未满足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按组件

  • 服务
  • 软件

第 8 章按规定类型

  • 基于网络
  • 基于云的
  • 本地

第 9 章，最终用户

  • 医院
  • 诊所
  • 诊断机构
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 按治疗类型划分的基准

第 12 章公司简介

  • 西门子医疗解决方案
    • 公司简介
    • 治疗类型组合和描述
    • 主要亮点
    • 财务摘要
  • Abbott Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche Ltd.
  • Orchard Software Corporation
  • Thermo Fisher Scientific Inc.
  • Randox Laboratories Ltd.
  • Hedera Biomedics srl
  • Seaward Electronic Ltd.
  • Esaote SpA

第 13 章全球医疗点数据管理系统市场 -DataM

简介目录
Product Code: DMHCIT804

Market Overview

Point Of Care Data Management Systems Market size was valued at US$ YY million in 2021 and is anticipated to reach US$ YY million by 2029, growing at a CAGR of 11.2% during the forecast period (2022-2029).

Point Of Care data management systems accelerate the recording, storing, and viewing of patients' medical records from multiple point-of-care devices at central data management systems. Also, these provide a bidirectional interface to hospitals and laboratory professionals on a single enterprise platform.

Market Dynamics

The point-of-care data management systems market growth is driven by technological advancements in data management systems such as remote monitoring, rising adoption of point-of-care data management systems, increase in the incidence of lifestyle diseases, and rise in healthcare expenditure.

The rising demand for point-of-care data management systems for health records is expected to drive the market growth

The rising adoption of point-of-care data management systems for health records is expected to boost the market over the forecast period. As per the article published in Practical Laboratory Medicine in November 2020, Accreditation and regulatory standards highlight the rising need to integrate POC Testing results into the patient's electric medical records. This promotes accessibility of POCT results, the ability to monitor and trend, prevents unnecessary repeat testing and provides evidence for patient outcomes. As POCT results are used to make clinical decisions, it is important to document results with associated reference intervals, units of measurements, critical values if applicable, date and time of testing, and also be traceable to device serial number, operator identification number, reagent lot number, and quality control (QC) results. POCT results should also be clearly differentiated from other central laboratory results to avoid confusion and trending results from different analytical methodologies. POCT is currently routine in all hospitals and has become the standard for patient care in a variety of other health care settings

In addition, the key players are adopting market strategies. For instance, in March 2020, Siemens Healthineers and Marienhaus Hospital Group collaborated on a ten-year technology partnership, with an option to lengthen for an additional five years. Siemens Healthineers is planning with Marienhaus for a digital strategy to interconnect 18 hospitals to streamline clinical processes. This may provide for the replacement and management of around 130 medical imaging devices in the German states of North Rhin.

The lack of skilled professionals will hamper the growth of the market

However, in the case of employees, cross-appointment to multiple wards and sites and the diverse range of employment types, such as full-time and part-time, increase the challenge of tracking active operators who are trained and have demonstrated competency. The lack of skilled professionals or employees working in healthcare to operate the data management systems limits the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global point of care data management systems market. As per an article published in Medical Laboratory Observer in May 2022, before the COVID-19 pandemic, POC testing was already experiencing robust growth and high acceptance. Due to the pandemic, more focus is on improving population health at more affordable costs. The case for POC testing is strong, especially when a quick, rapid turnaround time can profoundly impact downstream costs and patient outcomes. With the pandemic came a significant recognition of the value of POC testing and the importance of rapid test results, along with an increased demand for reliable testing methodologies. Key players respond to this demand with improved methodologies and interfaceable devices, which drive adoption. Because POC testing sites can be widely scattered across a healthcare campus, it is important to have a robust POC testing management system to capture important test information and manage regulatory compliance. The demand for POC increases leads to a demand for management systems in the market.

Segment Analysis

The cloud based segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The cloud based segment accounted for the largest market share in 2021. According to Philips data report, in June 2022, the requirement for data security and regulatory compliance has already motivated healthcare organizations to keep data on-premises. Nowadays, there is a rising awareness that moving to the cloud positively affects the segment in the market.

In fact, 60% of healthcare leaders now cite security as one of the top benefits of the cloud. When healthcare organizations depend on their own data centers, they are responsible for security from end to end, which can become prohibitively complex and time-consuming as IT infrastructures expand over time. Cloud-based services and solutions help to reduce dependency on local hardware to store sensitive data while automated software updates keep systems current.

Healthcare-compliant cloud platforms provide a flexible base for quick development and testing of digital applications. Cross-functional teams working in short and agile cycles are able to put novel digital applications into the hands of physicians or patients right away and then add new or improved features and functionalities as they gather additional user feedback. That means healthcare organizations get to innovate faster and in smaller, more digestible increments.

Geographical Analysis

North America region holds the largest market share of the global point of care data management systems market

North America dominates the market for point of care data management systems and is expected to show a similar trend over the forecast period. It is anticipated to hold a significant market size over the forecast period (2022-2029) owing to advanced healthcare, many key players and the rising population. National Institute of Biomedical Imaging and Bioengineering created the Point-of-Care Technologies Research Network (POCTRN) to drive the development of POC technologies through collaborative efforts that merge scientific and technological capabilities with the clinical need.

In addition, new technologies or products are being refined and improved to deliver easier-to-use devices with incremental improvements in analytical performance. Such advancements in newly launched devices drive the market in the North American region. For instance, in June 2020, DataLink Software (DataLink) highlighted the key advantages of Evoke360 and its Provider Relations Management (PRM) module, enabling providers to transition from fee-for-service to value-based care. Evoke360 serves as a point-of-care solution, aggregating data from disparate sources to accelerate preemptive patient care, closing gaps in care to treat more than the diagnosis results.

Competitive Landscape

The point of care data management systems market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Siemens Medical Solutions, Abbott Laboratories, Danaher Corporation, Hoffmann-La Roche Ltd., Orchard Software Corporation, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Hedera Biomedics SRL, Seaward Electronic Ltd., and Esaote SpA among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the global point-of-care data management systems market.

For instance,

  • In March 2020, Abbott introduced the molecular point-of-care "ID NOW" COVID-19 test, bringing rapid testing to the front lines. These tests run on Abbott's point-of-care ID NOW platform, a portable instrument, and provide fast results in many healthcare settings, such as physicians' offices, urgent care clinics, and hospital emergency departments. This is the company's second test to receive Emergency Use Authorization by the FDA for COVID-19 detection.

Siemens Medical Solutions

Overview:

Siemens is a German medical device company founded in 1847 and headquartered in Germany. It delivers lab-accurate, actionable, and timely results right away. Clinical management decisions can be made instantly from the ED to the physician's office, resulting in improved clinical outcomes, patient safety, and overall patient satisfaction.

Product Portfolio:

UniPOC Data Management System: It is an open data-management solution that connects and manages the largest ecosystems of point-of-care devices. It provides the POC system with an automated operator validation and recertification process and features active directory integration and compatibility with 64-bit databases and operating systems.

The global point of care data management systems market report would provide access to approximately 65+ market data tables, 65+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Component
  • 3.2. Market Snippet By Mode of Delivery
  • 3.3. Market Snippet By End-users
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancements
      • 4.1.1.2. Rising adoption of Electronic Health Records (EHR)
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of skilled professionals
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component Market Attractiveness Index, By Component
    • 7.1.2. Services*
    • 7.1.3. Introduction
    • 7.1.4. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.1.5. Software

8. By Mode of Delivery

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 8.1.2. Market Attractiveness Index, By Mode of Delivery
  • 8.2. Web-based*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Cloud Based
  • 8.4. On-premise

9. By End-users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 9.1.2. Market Attractiveness Index, By End-users
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Clinics
  • 9.4. Diagnostics Laboratories
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Treatment type Benchmarking

12. Company Profiles

  • 12.1. Siemens Medical Solutions*
    • 12.1.1. Company Overview
    • 12.1.2. Treatment type Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Abbott Laboratories
  • 12.3. Danaher Corporation
  • 12.4. Hoffmann-La Roche Ltd.
  • 12.5. Orchard Software Corporation
  • 12.6. Thermo Fisher Scientific Inc.
  • 12.7. Randox Laboratories Ltd.
  • 12.8. Hedera Biomedics srl
  • 12.9. Seaward Electronic Ltd.
  • 12.10. Esaote SpA

LIST NOT EXHAUSTIVE

13. Global Point Of Care Data Management Systems Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us